Mwanzo500660 • BOM
GlaxoSmithKline Pharmaceuticals Ltd
₹ 1,988.75
30 Jan, 12:57:08 GMT +5:30 · INR · BOM · Kanusho
HisaHisa zinazouzwa IN
Bei iliyotangulia
₹ 1,990.85
Bei za siku
₹ 1,984.00 - ₹ 2,016.95
Bei za mwaka
₹ 1,825.05 - ₹ 3,087.95
Thamani ya kampuni katika soko
336.59B INR
Wastani wa hisa zilizouzwa
elfu 3.26
Uwiano wa bei na mapato
50.22
Mgao wa faida
1.61%
Ubadilishanaji wa msingi
NSE
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(INR)Sep 2024Mabadiliko Tangu Mwaka Uliopita
Mapato
10.11B5.62%
Matumizi ya uendeshaji wa biashara
3.21B-2.94%
Mapato halisi
2.52B16.09%
Kiwango cha faida halisi
24.989.90%
Mapato kwa kila hisa
——
EBITDA
3.21B11.39%
Asilimia ya kodi ya mapato
26.56%—
Jumla ya mali
Jumla ya dhima
(INR)Sep 2024Mabadiliko Tangu Mwaka Uliopita
Uwekezaji wa pesa taslimu na vipindi vifupi
21.11B31.49%
Jumla ya mali
37.46B14.55%
Jumla ya dhima
20.73B19.80%
Jumla ya hisa
16.73B—
hisa zilizosalia
172.12M—
Uwiano wa bei na thamani
20.49—
Faida inayotokana na mali
——
Faida inayotokana mtaji
43.75%—
Mabadiliko halisi ya pesa taslimu
(INR)Sep 2024Mabadiliko Tangu Mwaka Uliopita
Mapato halisi
2.52B16.09%
Pesa kutokana na shughuli
——
Pesa kutokana na uwekezaji
——
Pesa kutokana na ufadhili
——
Mabadiliko halisi ya pesa taslimu
——
Mtiririko huru wa pesa
——
Kuhusu
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
Ilianzishwa
13 Nov 1924
Wafanyakazi
3,211
Tafuta
Futa utafutaji
Funga kisanduku cha kutafutia
Programu za Google
Menyu kuu